A case of new onset refractory status epilepticus in a US traveler with Japanese encephalitis

被引:0
|
作者
Osbourn, Spencer R. [1 ]
Ryan, Keith E. [1 ]
Cannard, Kevin R. [1 ]
Ma, Yitao [1 ]
机构
[1] Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Wisconsin Ave, Bethesda, MD 20889 USA
关键词
Japanese encephalitis; NORSE; Anti-NMDAR encephalitis; RECEPTOR ENCEPHALITIS; SEIZURES;
D O I
10.1016/j.jneuroim.2023.578193
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New onset refractory status epilepticus (NORSE) is a rare but critical condition characterized by refractory status epilepticus (RSE) in an individual without prior history of epilepsy or known structural, toxic, or metabolic cause. Postinfectious immune activation is an important cause of NORSE. Early testing for autoimmune antibodies is strongly recommended (Wickstrom et al., 2022). We report a case of NORSE triggered by Japanese encephalitis (JE) in an unvaccinated US adult traveler. Her CSF later revealed positive anti-N-methyl-D-aspartate (NMDA)-receptor antibody. The patient responded well to first line immunotherapy with favorable functional outcome. This case highlights the diagnostic and treatment challenges in this rare presentation.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Refractory status epilepticus behind autoimmune encephalitis
    Zummo, Leila
    Coco, Daniele Lo
    Lopez, Gianluca
    Palma, Daniela
    Daniele, Ornella
    NEUROLOGICAL SCIENCES, 2020, 41 (05) : 1291 - 1295
  • [42] Refractory status epilepticus behind autoimmune encephalitis
    Leila Zummo
    Daniele Lo Coco
    Gianluca Lopez
    Daniela Palma
    Ornella Daniele
    Neurological Sciences, 2020, 41 : 1291 - 1295
  • [43] Neuropathology of New-Onset Refractory Status Epilepticus (NORSE)
    Hanin, Aurelie
    Cespedes, Jorge
    Huttner, Anita
    Strelnikov, David
    Gopaul, Margaret
    DiStasio, Marcello
    Vezzani, Annamaria
    Hirsch, Lawrence J.
    Aronica, Eleonora
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 3688 - 3702
  • [44] Efficacy of Tocilizumab in New-Onset Refractory Status Epilepticus
    Jun, J. -S.
    Lee, S. -T.
    Lee, H. -W.
    Lee, S.
    Chu, K.
    EPILEPSIA, 2018, 59 : S353 - S353
  • [45] NEW ONSET REFRACTORY STATUS EPILEPTICUS: OUTCOMES AND ROLE OF IMMUNOTHERAPY
    McHugh, C.
    Mohanraj, R.
    EPILEPSIA, 2011, 52 : 74 - 75
  • [46] Autopsy Findings in New-onset Refractory Status Epilepticus
    Healy, Courtney
    Chandra, Rahul
    Valeriano, James
    Gyure, Kymberly
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 578 - 578
  • [47] Neuropathology of New-Onset Refractory Status Epilepticus (NORSE)
    Aurélie Hanin
    Jorge Cespedes
    Anita Huttner
    David Strelnikov
    Margaret Gopaul
    Marcello DiStasio
    Annamaria Vezzani
    Lawrence J. Hirsch
    Eleonora Aronica
    Journal of Neurology, 2023, 270 : 3688 - 3702
  • [48] Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
    Donnelly, Jonathan P.
    Kasatwar, Nidhi
    Hafeez, Shaheryar
    Seifi, Ali
    Gilbert, Andrea
    Barthol, Colleen
    Small, Clay
    Szabo, C. Akos
    EPILEPSY & BEHAVIOR REPORTS, 2021, 15
  • [49] New onset refractory status epilepticus research What is on the horizon?
    Gofton, Teneille E.
    Gaspard, Nicolas
    Hocker, Sara E.
    Loddenkemper, Tobias
    Hirsch, Lawrence J.
    NEUROLOGY, 2019, 92 (17) : 802 - 810
  • [50] The seasonality of new-onset refractory status epilepticus (NORSE)
    Gopaul, Margaret T.
    Hanin, Aurelie
    Cespedes, Jorge
    Pulluru, Yashwanth
    Kazazian, Karnig
    van Baalen, Andreas
    Gofton, Teneille E.
    Gaspard, Nicolas
    Hirsch, Lawrence J.
    EPILEPSIA, 2023, 64 (06) : E112 - E117